Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 3

2(28.6%)

7Total

N/A(5)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06466031Not ApplicableRecruiting

Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO]

Role: lead

NCT07127380Not ApplicableRecruiting

Comparison of Clinical Outcomes, Complications Rate and Treatment Costs of Mini-TLIF and MIDLIF in the Treatment of Discogenic Low Back Pain

Role: lead

NCT06527027Not ApplicableRecruiting

LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes

Role: lead

NCT06293157Not ApplicableRecruiting

Carbon Fiber Transpedicular Screws in Treatment of Spinal Metastatic Disease

Role: lead

NCT06529081Not ApplicableRecruiting

Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer

Role: lead

NCT02072811Phase 3Unknown

Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia

Role: collaborator

NCT01535209Phase 3Unknown

Stereotactic Radiotherapy of Resection Cavity For Single Brain Metastasis Versus Whole-Brain Radiotherapy After Resection

Role: collaborator

All 7 trials loaded